Article
Chimeric antigen receptor signaling: Functional consequences and design implications
20 May 2020
Abstract excerpt
Chimeric antigen receptor (CAR) T cell therapy has transformed the care of refractory B cell malignancies and holds tremendous promise for many aggressive tumors. Despite overwhelming scientific, clinical, and public interest in this rapidly expanding field, fundamental inquiries into CAR T cell mechanistic functioning are still in their infancy. Because CAR T cells are manufactured from donor T lymphocytes, and...
Topics
Join the communities discussing this publication.
